Skip to main content

Table 1 Baseline characteristics of patients in the atrial fibrillation (AF) and sinus rhythm (SR) groups

From: YKL-40 is highly expressed in the epicardial adipose tissue of patients with atrial fibrillation and associated with atrial fibrosis

Variables

SR group (n = 36)

AF group (n = 28)

χ2/t

P

Demographics

 Age (year)

67.8 ± 8.8

66.5 ± 8.1

0.605

0.547

 Gender (percent male)

20 (55.6%)

16 (57.1%)

0.016

0.899

 BMI (kg/m2)

23.8 ± 2.9

25.6 ± 3.6

1.652

0.104

 Smoking

10 (27.8%)

8 (28.6%)

0.005

0.944

NYHA functional class

  

2.709

0.439

 I

5 (13.9%)

3 (10.7%)

  

 II

12 (33.3%)

12 (42.9%)

  

 III

16 (44.4%)

8 (28.6%)

  

 IV

3 (8.3%)

5 (17.9%)

  

Echocardiography

 LVEF (%)

58.8 ± 4.4

59.3 ± 5.0

0.391

0.697

 LAD (mm)

37.9 ± 5.8

43.8 ± 3.9

4.547

< 0.001

Comorbidities

 Hypertension

10 (27.8%)

6 (21.4%)

0.339

0.561

 T2DM

12 (33.3%)

8 (28.6%)

0.166

0.683

 Stroke

2 (5.6%)

4 (14.3%)

1.413

0.235

 COPD

4 (11.1%)

4 (14.3%)

0.145

0.703

Serum YKL-40 (μg/l)

87.0 ± 36.6

101.5 ± 41.5

1.475

0.145

  1. BMI body mass index, LVEF left ventricular ejection fraction, LAD left atrial diameter, T2DM type 2 diabetes mellitus, COPD chronic obstructive pulmonary disease, NYHA New York Heart Association